ENTITY
Eris Lifesciences

Eris Lifesciences (ERIS IN)

42
Analysis
Health CareIndia
Eris Lifesciences Limited manufactures, markets, and sells generic drugs. The Company focuses on cardiology, diabetology, endocrinology, gastroenterology, ENT, orthopedics, pediatrics, and gynecology segments. Eris Lifesciences distributes pharmaceutical drugs throughout India. v
more
bullishSmartkarma
01 Jul 2017 11:56

Smartkarma: ECM Coverage Weekly Update (1 July 2017)

The Smartkarma ECM Team puts out a weekly update on the deals we have covered recently, along with updates for upcoming IPOs. This week, Tejas...

Share
17 Jun 2017 09:12

Eris Lifesciences IPO - Rich Valuations at What Appears to Be Unsustainably High Margins

Eris Lifesciences plans to raise US$270m in its IPO through a selldown of shares by a ChrysCapital, a PE investor, and the founders. Our fellow...

Logo
477 Views
Share
15 Jun 2017 12:02

Eris Lifesciences: Ask Some Questions, Take the Deal

Eris Lifesciences Limited (0113824Z IN) is an India-focused pharmaceutical company that produces and markets branded generic drugs. The company...

Share
x